Mike Petroutsas, president and head of U.S. commercial at Astellas, explores the importance of insight-driven commercialization in reshaping how manufacturers engage patients, physicians and the broader healthcare ecosystem.
Mike Petroutsas
Advertisement
The president and head of U.S. commercial at Astellas. Prior to Astellas, Petroutsas served as senior vice president, U.S. Specialty and Oncology Business, at GSK. There he successfully launched the US Oncology division and focused on commercializing medicines to help many patients with complex diseases in immunology, hepatology, respiratory and renal areas. Before that, he held senior positions at Pfizer and Novartis Oncology.
Articles by Mike Petroutsas
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
4
Pharmaceutical Executive Daily: FDA Approves Baxdrostat
5